Navigation Links
CIO Leadership Series: Kim Pemble, SynergyHealth

nd information services," he said.

That, he said, should be a more consistent way of looking at IT projects than he has witnessed in a variety of industries, including healthcare. Prior to joining Synergy Health, he served as a principal for Information eVolution Consulting, an advisor to healthcare organizations, as an assistant professor in the Colleg......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 07/29/06


Page: 1 2 3 4

Related biology technology :

1. CIO Leadership Series: Snap-Ons Moreno offers lessons in IT transformation
2. CIO Leadership Series: Logothetis likes CIOs evolving role
3. CIO Leadership Series: Phil Loftus, Aurora Health Care
4. CIO Leadership Series: Deb Rislow, Gundersen Lutheran
5. CIO Leadership Series: Judy Lemke, Schneider National
6. CIO Leadership Series: Tanya Townsend, Saint Clares Hospital
7. CIO Leadership Series: Greg Smith, Wheaton Franciscan Healthcare
8. CIO Leadership Series: Rick Davidson, Manpower
9. CIO Leadership Series: Mike Sauk, UW Hospital and Clinics
10. CIO Leadership Series: Ed Meachen, University of Wisconsin System
11. CIO Leadership Series: Byrne Chapman, American Family Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: CIO Leadership Series Kim Pemble SynergyHealth

(Date:12/24/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... Shandong Taibang Biological Products Co. Ltd., has received ... Food and Drug Administration (the "CFDA") for its ... in the Company,s public filings, the CFDA inspected ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
(Date:12/22/2014)... 22, 2014 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, announced ... University of Calgary in conjunction with co-authors from Kyoto ... validates the company,s ongoing clinical research using dermal sheath ... baldness. The paper entitled " Hair Follicle ...
(Date:12/22/2014)... December 22, 2014 The ... publication of original research, reviews and editorials addressing ... clinical practice, today published a provocative article exploring ... development, progression and potential treatment of prostate cancer. ... research and proposes the possibility that there could ...
Breaking Biology Technology:China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... Reports Financial Results for the 12 Months Ended December ... A/S,(OMX: GEN) announced today results for the financial year ... (approximately USD 104 million) compared to,DKK 136 million (approximately ... of DKK 437 million (approximately USD 86 million).,This compares ...
... (OTC Bulletin Board: IMYN), a biotechnology firm that ... to,the biopharmaceutical SF-1019, has announced its results for ... the year ended December 31, 2007, the company ... in interest expense which,was funded from advances by ...
... Elbit Imaging Ltd.,(Nasdaq: EMITF ) ("EI" or ... year 2007., Transition to IFRS, Through ... been,prepared in accordance with generally accepted accounting principles ... provisions of Standard 29 of the Israeli,Accounting Standard ...
Cached Biology Technology:Genmab Announces Year End 2007 Financial Results 2Genmab Announces Year End 2007 Financial Results 3Genmab Announces Year End 2007 Financial Results 4Genmab Announces Year End 2007 Financial Results 5Immunosyn Corporation Announces 2007 Results, Files 10KSB 2Immunosyn Corporation Announces 2007 Results, Files 10KSB 3Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 2Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 3Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 4Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 5Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 6Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 7Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 8Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 9Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 10Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 11Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 12Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 13Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 14Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 15Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 16
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ... technology is accurate, flexible and robust – with the ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. ... the adoption of multimodal biometric systems. Multimodal biometric ... individual for verification and identification purposes. This helps ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... University researchers have received a $1.5 million federal ... account of their ecological footprint., Seven researchers in ... Resources, Biosystems Engineering, and USDA Agricultural Research Service ... elements central to farming and out of balance ...
... purification of drug components is a large hurdle facing ... that utilize proteins, which are notoriously difficult to separate ... for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic ... and improve an important protein purification process. ...
... new class of drug designed to target the hepatitis ... some of the HCV strains being treated exhibited signs ... of Florida State University biologists, chemists and biomedical researchers ... the drug-resistant HCV strains and the molecular-level mechanisms that ...
Cached Biology News:WSU researchers taking sustainability of organic farming to new level 2Purifying proteins: Rensselaer researchers use NMR to improve drug development 2Purifying proteins: Rensselaer researchers use NMR to improve drug development 3Hepatitis C virus faces new weapon from Florida State scientists 2Hepatitis C virus faces new weapon from Florida State scientists 3
GEL FILTRATION CAL KIT HMW, 1 EA. *Category: Gel Filtration Gels....
Mouse monoclonal [6C3] to JAB1 ( Abpromise for all tested applications). entrezGeneID: 10987 SwissProtID: O15386...
Human TGF-beta RIIb Affinity Purified Polyclonal Ab...
Human FGF R2 (alpha isoforms) MAb (Clone 98706)...
Biology Products: